Viz.ai and Illuminate Expand Partnership for Cerebral Aneurysm Patient Care

January 30, 2025—Viz.ai announced an expanded partnership with Softek Illuminate, Inc. The company stated that the partnership seeks to enable health care providers to make timely decisions for patients with cerebral aneurysms while ensuring patients are not lost to follow-up.

Viz.ai develops artificial intelligence (AI)–powered disease detection and intelligent care coordination. Illuminate is a developer of natural language processing and AI software that discovers at-risk patients from electronic medical records, assesses disease severity, and facilitates follow-up surveillance for a variety of diseases.

According to Viz.ai, the company’s Viz Aneurysm leverages AI to automatically analyze CT angiograms (CTAs) for suspected cerebral aneurysm and streamline referrals. Illuminate’s Discovery360 incorporates the people, process, and technology to identify and monitor lost aneurysm patients.

After screening approximately 1,200 CTAs for stroke evaluation across eight stroke centers, Viz Aneurysm helped determine that 85% of aneurysms had not been previously referred to neurology for follow-up. Together, Viz Aneurysm and Illuminate’s Discovery360 equip care teams with the clinical insights they need to ensure timely diagnosis and patient follow-up, stated Viz.ai.